Life on Silicon
Building a future in which the entire drug discovery pipelines happen on computers using artificial organs and organisms
Video Credit: Bruno Vellutini
We specialize in bridging the gap between artificial intelligence and biology, driving transformative advancements in our understanding of human health.
Accelerate drug discovery and development without the need for any preclinical animal testing
92% of animal findings fail to translate to humans [1]
89% of animal studies cannot be reproduced [2]
94% of drugs that pass animal testing will fail during human clinical trials [3]
[1] Mak, Isabella WY, Nathan Evaniew, and Michelle Ghert. “Lost in translation: animal models and clinical trials in cancer treatment.” American journal of translational research 6.2 (2014): 114.
[2] Freedman, Leonard P., Iain M. Cockburn, and Timothy S. Simcoe. “The economics of reproducibility in preclinical research.” PLoS biology 13.6 (2015): e1002165.
[3] Bunnage, Mark E. “Getting pharmaceutical R&D back on target.” Nature chemical biology 7.6 (2011): 335-339
Learn more!
Contact us to learn more about our platform and products
In-silico Cellular Reprogramming